Suppr超能文献

123I标记的HIV-1反式激活因子肽放射免疫缀合物被导入人乳腺癌细胞的细胞核,并在体外和体内与细胞周期蛋白依赖性激酶抑制剂p21(WAF-1/Cip-1)发生功能相互作用。

123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).

作者信息

Hu Meiduo, Chen Paul, Wang Judy, Scollard Deborah A, Vallis Katherine A, Reilly Raymond M

机构信息

Division of Nuclear Medicine, University Health Network, Toronto, ON, Canada.

出版信息

Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):368-77. doi: 10.1007/s00259-006-0189-0. Epub 2006 Sep 26.

Abstract

PURPOSE

To evaluate the internalization and nuclear translocation of (123)I-tat-peptide radioimmunoconjugates in MDA-MB-468 breast cancer cells and their ability to interact with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).

METHODS

Peptides [GRKKRRQRRRPPQGYGC] harboring the nuclear-localizing sequence from HIV tat domain were conjugated to anti-p21(WAF-1/Cip-1) antibodies. Immunoreactivity was assessed by Western blot using lysate from MDA-MB-468 cells exposed to EGF to induce p21(WAF-1/Cip-1). Internalization and nuclear translocation were measured. The ability of tat-anti-p21(WAF-1/Cip-1) to block G(1)-S phase arrest in MDA-MB-468 cells caused by EGF-induced p21(WAF-1/Cip-1) was evaluated. Tumor and normal tissue uptake were determined at 48 h p.i. in athymic mice implanted s.c. with MDA-MB-468 xenografts injected intratumorally with EGF.

RESULTS

There was 13.4+/-0.2% of radioactivity internalized by MDA-MB-468 cells incubated with (123)I-tat-anti-p21(WAF-1/Cip-1) and 34.6+/-3.1% imported into the nucleus. Tat-anti-p21(WAF-1/Cip-1)(8 muM) decreased the proportion of EGF-treated cells in G(1) phase from 81.9+/-0.7% to 46.1+/-0.7% (p<0.001), almost restoring the G(1) phase fraction to that of unexposed cells (25.8+/-0.2%). Non-specific tat-mouse IgG did not block EGF-induced G(1)-S phase arrest. Tumor uptake of radioactivity was higher in mice injected with EGF to induce p21(WAF-1/Cip-1) than in mice not receiving EGF (3.1+/-0.4% versus 1.8+/-0.2% ID/g; p=0.04). Western blot analysis of tumors revealed a threefold increase in the p21(WAF-1/Cip-1)/beta-actin ratio.

CONCLUSION

We conclude that intracellular and nuclear epitopes in cancer cells can be functionally targeted with tat-radioimmunoconjugates to exploit many more epitopes for imaging and radiotherapeutic applications than have previously been accessible.

摘要

目的

评估(123)I - tat - 肽放射性免疫缀合物在MDA - MB - 468乳腺癌细胞中的内化和核转位,以及它们与细胞周期蛋白依赖性激酶抑制剂p21(WAF - 1/Cip - 1)相互作用的能力。

方法

将携带来自HIV tat结构域核定位序列的肽[GRKKRRQRRRPPQGYGC]与抗p21(WAF - 1/Cip - 1)抗体偶联。使用来自暴露于表皮生长因子(EGF)以诱导p21(WAF - 1/Cip - 1)的MDA - MB - 468细胞的裂解物,通过蛋白质印迹法评估免疫反应性。测量内化和核转位情况。评估tat - 抗p21(WAF - 1/Cip - 1)阻断MDA - MB - 468细胞中由EGF诱导的p21(WAF - 1/Cip - 1)引起的G1 - S期阻滞的能力。在皮下植入MDA - MB - 468异种移植物并瘤内注射EGF的无胸腺小鼠中,于注射后48小时测定肿瘤和正常组织摄取情况。

结果

与(123)I - tat - 抗p21(WAF - 1/Cip - 1)孵育的MDA - MB - 468细胞内化了13.4±0.2%的放射性,34.6±3.1%进入细胞核。Tat - 抗p21(WAF - 1/Cip - 1)(8μM)使EGF处理的G1期细胞比例从81.9±0.7%降至46.1±0.7%(p<0.001),几乎将G1期比例恢复到未暴露细胞的水平(25.8±0.2%)。非特异性tat - 小鼠IgG未阻断EGF诱导的G1 - S期阻滞。注射EGF以诱导p21(WAF - 1/Cip - 1)的小鼠的肿瘤放射性摄取高于未接受EGF的小鼠(3.1±0.4%ID/g对1.8±0.2%ID/g;p = 0.04)。肿瘤的蛋白质印迹分析显示p21(WAF - 1/Cip - 1)/β - 肌动蛋白比率增加了三倍。

结论

我们得出结论,癌细胞中的细胞内和核表位可用tat - 放射性免疫缀合物进行功能靶向治疗,以开发比以前更多的表位用于成像和放射治疗应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验